Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data
Proton-pump inhibitors, PPIs, are widely prescribed and are available over the counter for prolonged reduction of stomach acid production and related disorders. PPIs irreversibly inhibit the hydrogen/potassium ATPase in gastric parietal cells. Recent retrospective studies have described an associati...
Saved in:
Main Authors: | Tigran Makunts (Author), Haroutyun Joulfayan (Author), Kenneth Ta (Author), Ruben Abagyan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
by: Svetlana Garafola, et al.
Published: (2023) -
Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023) -
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021) -
RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017) -
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
by: E. V. Shubnikova
Published: (2024)